Interim pathway to notify parents of a baby's Sickle Cell and other Haemoglobin carrier results identified under the NHS England Newborn bloodspot Screening (NBS) programme in Derbyshire [Urgent Award]

Concepts

• health services
• derby
• other nbs results
• other haemoglobin carrier results
• sickle cell
• babies
• the clinical sickle cell carrier service
• interim pathway
• pathway provision
• parents

Location

East Midlands England: DHU Health Care Johnson Building, Locomotive Way Derby DE24 8PU

Geochart for 1 buyers and 1 suppliers

NHS England Midlands East

+−

Leaflet | Map tiles by Stamen Design, under CC BY 3.0. Data by OpenStreetMap, under ODbL.

Description

NHS England - Midlands (East) are making an urgent award for the Provision of Interim pathway to notify parents of Sickle Cell & other Haemoglobin carrier results identified during NBS Screening in Derbyshire.

Total Quantity or Scope

The contract is to deliver an interim pathway to notify parents of their babies Sickle Cell & other Haemoglobin carrier results identified during NBS screening programme in Derbyshire. NHS England - Midlands (East) are making an urgent award to the existing provider DHU Healthcare as described in regulation 14 of the Health Care Services (Provider Selection Regime) Regulations 2023. Following an incident and audit, there was a clear recommendation for a clinical service to provide the Sickle Cell Carrier (SCC) results to babies born with a SCC. The responsibility for commissioning the clinical sickle cell carrier service sits with NHS Derby and Derbyshire Integrated Care Board (ICB), due to the timeframes to implement and recruit to the new service commissioned by the ICB, NHS England - Midlands (East) have agreed to commission this service on an interim basis until the permanent pathway is in place in January 2025. This date is subject to successful recruitment of staff for the ICB service therefore this contract will be let until 31st March 2025 and terminated early when the substantive service is operational. This will ensure there is no gap in pathway provision. Failure to provide this service will further delay the sickle cell carrier status notification and other not suspected NBS results to parents of babies screened since 20th June 2024. It will create a health inequality as babies with other NBS results are notified in a shorter timeframe. Therefore this contract is being awarded to DHU Healthcare as they are the current provider for the sickle cell serious incident response. The lifetime value of this contract is £4,309. Services will be provided between 4th November 2024 and 31st March 2025.

Award Detail

Award Criteria

CPV Codes

• 85100000 - Health services

Legal Justification

This is a Provider Selection Regime (PSR) confirmation of contract award notice. This contract has been awarded under the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to this award.

Other Information

** PREVIEW NOTICE, please check Find a Tender for full details. ** This contract has been awarded under the urgent circumstances provision of the Provider Selection Regime (PSR). This contract has been awarded under the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to this award. The decision to use Regulation 14 to award under urgent circumstances was made due to the need to ensure there is no gap in pathway provision. Failure to provide this service will increase the backlog of babies waiting for results and create a health inequality as babies with other NBS results are notified in a shorter timeframe. There were no declared or potential conflicts of interest. The decision makers for this process are Midlands Commissioning Group (MCG).